Marker Therapeutics Inc (NASDAQ:MRKR)
| 0.3351 Delayed Data As of May 17 |  +0.0251 / +8.10%Today’s Change | 0.28 Today|||52-Week Range 3.65 | -64.73% Year-to-Date |
Latest MRKR News | Press Releases
No recent news for Marker Therapeutics Inc.
Today’s Trading
| Previous close | 0.31 |
| Today’s open | 0.32 |
| Day’s range | 0.31 - 0.35 |
| Volume | 165,806 |
| Average volume (3 months) | 615,139 |
| Market cap | $27.4M |
Data as of 05/17/2022
Growth & Valuation
| Earnings growth (last year) | +10.29% |
| Earnings growth (this year) | +15.91% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +166.01% |
| P/E ratio | -- |
| Price/Sales | 58.54 |
| Price/Book | 0.62 |
Competitors
Data as of 05/17/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$41.9M |
| Net profit margin | -3,372.68% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Houston, Texas |
Forecasts
